A Phase I Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer

MLA

Jacob Witt, et al. “A Phase I Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer.” International Journal of Radiation Oncology*Biology*Physics, vol. 108, Oct. 2020, pp. E7–8. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........90cc9a14cd0ab9787196fff071552115&authtype=sso&custid=ns315887.

APA

Jacob Witt, Aleksandra Kuczmarska-Haas, Daniel Abbott, Sharon Weber, Rebecca Minter, Sean Ronnekleiv-Kelly, Noelle LoConte, Daniel Mulkerin, Sam Lubner, Nataliya Uboha, Dustin Deming, Adam Bayliss, Mark Ritter, Pranshu Mohindra, & Michael Bassetti. (2020). A Phase I Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics, 108, E7–E8.

Chicago

Jacob Witt, Aleksandra Kuczmarska-Haas, Daniel Abbott, Sharon Weber, Rebecca Minter, Sean Ronnekleiv-Kelly, Noelle LoConte, et al. 2020. “A Phase I Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer.” International Journal of Radiation Oncology*Biology*Physics 108 (October): E7–8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........90cc9a14cd0ab9787196fff071552115&authtype=sso&custid=ns315887.